Nanjing Leads Biolabs (9887) Announces Inclusion in MSCI Global Small Cap Indexes

Bulletin Express
11/07

Nanjing Leads Biolabs Co., Ltd. (Stock Code: 9887) announced that its shares will be included in the MSCI Global Small Cap Indexes effective after the market close on November 24, 2025. This inclusion, compiled by Morgan Stanley Capital International, is designed to track the performance of smaller-capitalization companies in international markets.

According to the official announcement, the inclusion highlights investor recognition of Nanjing Leads Biolabs’ operating performance and potential for further development. Shareholders and potential investors are advised to exercise due care when trading the company’s shares. The board of directors reiterates that the inclusion in the MSCI Global Small Cap Indexes is a key milestone in the company’s ongoing growth and engagement with the global investment community.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10